Navigation Links
ThreeWire Expands Presence in the Pharmaceutical Arena
Date:5/27/2008

Utilizes extensive experience in medical device industry to benefit

pharmaceutical clinical trial recruitment efforts

MINNEAPOLIS, May 27 /PRNewswire/ -- Leading clinical trial recruitment and direct-to-patient marketing firm ThreeWire has strengthened the pharmaceutical side of its business with the addition of two directors of business development and a commitment to leveraging differentiators unique to the medical device industry on behalf of pharmaceutical industry clients.

According to ThreeWire CEO and President, Mark Summers, "In the world of medical device clinical research studies, you have to motivate patients to agree to have a device surgically implanted in their body. Add to that a restrictive protocol, and you are now recruiting from a narrow, hard-to-reach patient population that must be prepared to undergo a highly invasive surgical procedure. Success depends on a system that targets only the most qualified patients and keeps them engaged throughout the healthcare continuum. It is that experience we are using to drive enrollment for pharmaceutical clinical trials."

In order to help pharmaceutical companies in their patient recruitment efforts, ThreeWire has hired Janine Katz and Shannon McDonnell. Katz is a business development professional with over ten years of experience in clinical trial patient recruitment and public relations programs in the pharmaceutical and healthcare industries. McDonnell brings leadership skills in business development in the healthcare field, including two years focused solely on clinical trial recruitment. Both will report to Jim Suddendorf, Senior Vice President, Business Development and Client Services.

"As the regulatory bar is being raised and greater numbers of patients are being required for trial completion, the challenge of patient recruitment is being elevated," adds Suddendorf. "Successful enrollment solutions depend on a systematic marketing approach, which is exactly what ThreeWire offers."

To deliver results, ThreeWire offers a full array of in-house services, including concept development, advertising, media planning and buying, and optimized website development, as well as site-based support and portal tools. Contract study coordinators can conduct patient record screenings, process patient referrals and assist with informed consent. ThreeWire also features a multi-lingual nurse-staffed call center and grassroots outreach.

For more information, contact sales@threewire.com.

Since 1999, ThreeWire has been delivering premier services and offering strategic and tactical solutions that result in measurable growth, global brand recognition and market leadership to the medical device, pharmaceutical and biotech industries. In addition to clinical trial recruitment and direct-to-patient marketing, ThreeWire also offers Recall Response Services with 24/7 call center capabilities.

For more information, contact:

Annie Garvey

952-852-5572

agarvey@threewire.com


'/>"/>
SOURCE ThreeWire
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
2. DuPont Expands Animal Health Solutions Business in Asia
3. Hospira Expands Board of Directors
4. Sidec AB Expands Into New Offices
5. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
6. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
7. Quintiles Consulting Business Expands
8. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
9. BrainCells Inc. Expands Series B Financing to $50 Million
10. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
11. SeqWright Expands Next Generation Lineup with the Addition of 454s GS FLX(TM) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Australian-US drug discovery and development company, Novogen Limited (ASX:NRT; NASDAQ: ... Chairman, Mr John O,Connor , and new Deputy Chairman, ... James Garner , has also been formally appointed to the ... Iain Ross , will resume his role on the ... , has also been formally appointed to the Board as ...
(Date:2/4/2016)... Falls Church, VA (PRWEB) , ... ... ... a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes ... Bloomsburg, PA. The two-day event features 20+ speakers and activities such as ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
(Date:2/4/2016)... ... 2016 , ... Many of the engineers at FireflySci, Inc. have been manufacturing ... apart from other cuvette manufacturers is their supercharged customer service and their extensive database ... this steady flow of inside information, they have recently revamped their manufacturing techniques to ...
Breaking Biology Technology:
(Date:1/7/2016)... Jan. 7, 2016 This BCC Research report ... biometric technologies and devices, identifying newer markets and exploring ... types of biometric devices. Includes forecast from 2015 to ... newer markets and explore the expansion of the present ... each type of biometric technology, determine its current market ...
(Date:1/7/2016)...  A United States District Court in ... country to interpret a biometric privacy statute in a ... the photo website Shutterfly brought by the law firm Carey ... vs. SHUTTERFLY, INC.; and THISLIFE, INC ( N.D. Ill ... the Illinois Biometric Privacy Act by collecting and scanning ...
(Date:1/6/2016)... Jan. 6, 2016 Based on its ... & Sullivan recognizes MorphoTrak, LLC, a U.S. subsidiary ... Frost & Sullivan Company of the Year Award. ... technology, Morpho Wave™ , has consolidated the company,s ... biometrics market. Morpho Wave is a highly ...
Breaking Biology News(10 mins):